Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial

出版年份 2020 全文链接

标题

作者

关键词

clinical trial, metastatic castration-resistant prostate cancer, nivolumab, ipilimumab, immunotherapy, tumor mutational burden, DNA damage repair, biomarkers

出版物

CANCER CELL

Volume 38, Issue 4, Pages 489-499.e3

出版商

Elsevier BV

发表日期

2020-09-10

DOI

10.1016/j.ccell.2020.08.007

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now